Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium-Reference-Cited by-同舟云学术

Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium

Published:1988-04 Issue:4 Volume:158 Page:796-805
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Ehrlich Clarence E.,Young Peter C.M.,Stehman Frederick B.,Sutton Gregory P.,Alford William M.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology

Reference18 articles.

1. Role of steroid hormone receptors as prognostic factors in primary breast cancer;McGuire;Natl Cancer Inst Monogr,1986

2. Endometrial cancer. The emergence of therapeutic individualization;Boronow;Prog Gynecol,1983

3. Management of endometrial adenocarcinoma stage I with surgical staging followed by tailored adjuvant radiation therapy;DiSaia;Clin Obstet Gynecol,1986

4. Progesterone binding in human endometrial adenocarcinomas;Young;Am J Obstet Gynecol,1976

5. The effect of estrogen receptor status on survival in patients with endometrial cancer;Martin;Am J Obstet Gynecol,1983

Cited by 184 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling Residual Diseases of Endometrial Precancer/Cancer After Progestin Therapy;Gynecologic and Obstetric Pathology;2024

2. Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma;BMC Cancer;2023-11-03

3. Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma;Cancers;2022-12-15

4. Reproductive advance of fertility preservation in patients with early endometrial carcinoma or endometrial atypical hyperplasia;Gynecology and Obstetrics Clinical Medicine;2022-12

5. SWI/SNF Antagonism of PRC2 Mediates Estrogen-Induced Progesterone Receptor Expression;Cells;2022-03-15